Clinical Efficacy of Intravenous Lidocaine for Thyroidectomy: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial

2016 ◽  
Vol 40 (12) ◽  
pp. 2941-2947 ◽  
Author(s):  
Geun Joo Choi ◽  
Hyun Kang ◽  
Eun Jin Ahn ◽  
Jong In Oh ◽  
Chong Wha Baek ◽  
...  
Keyword(s):  
Clinical Efficacy ◽  
Controlled Trial ◽  
Intravenous Lidocaine ◽  
Double Blind ◽  
Double Blind Placebo

Clinical efficacy of specific immunotherapy to cat dander: a double-blind placebo-controlled trial

1997 ◽  
Vol 27 (8) ◽  
pp. 860-867 ◽  
Author(s):  
V.A. VARNEY ◽  
J. EDWARDS ◽  
K. TABBAH ◽  
H. BREWSTER ◽  
G. MAVROLEON ◽  
...  
Keyword(s):  
Clinical Efficacy ◽  
Specific Immunotherapy ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo

Clinical efficacy of specific immunotherapy to cat dander: a double-blind placebo-controlled trial

1997 ◽  
Vol 27 (8) ◽  
pp. 860-867 ◽  
Author(s):  
V.A. VARNEY ◽  
J. EDWARDS ◽  
K. TABBAH ◽  
H. BREWSTER ◽  
G. MAVROLEON ◽  
...  
Keyword(s):  
Clinical Efficacy ◽  
Specific Immunotherapy ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals Clinical efficacy of potassium humate in the treatment of allergic rhinitis: double-blind placebo-controlled trial

2010 ◽  
Vol 71 (6) ◽  
pp. 358-363 ◽  
Author(s):  
Justin J. Gandy ◽  
Johanna P. Meeding ◽  
Jacques R. Snyman ◽  
Constance E. Jansen van Rensburg
Keyword(s):  
Allergic Rhinitis ◽  
Clinical Efficacy ◽  
Controlled Trial ◽  
Double Blind ◽  
Potassium Humate ◽  
Double Blind Placebo

scholarly journals The Effect of Intravenous Lidocaine on Trigeminal Neuralgia: A Randomized Double Blind Placebo Controlled Trial

ISRN Pain ◽  
2014 ◽  
Vol 2014 ◽  
pp. 1-5 ◽  
Author(s):  
Evmorfia Stavropoulou ◽  
Erifili Argyra ◽  
Panagiotis Zis ◽  
Athina Vadalouca ◽  
Ioanna Siafaka
Keyword(s):  
Trigeminal Neuralgia ◽  
Controlled Trial ◽  
Line Treatment ◽  
Intravenous Lidocaine ◽  
Inclusion Criteria ◽  
First Line ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Therapeutic Results ◽  
First Line Treatment

Trigeminal neuralgia is the most common neuralgia. Its therapeutic approach is challenging as the first line treatment often does not help, or even causes intolerable side effects. The aim of our randomized double blind, placebo controlled, crossover study was to investigate in a prospective way the effect of lidocaine in patients with trigeminal neuralgia. Twenty patients met our inclusion criteria and completed the study. Each patient underwent four weekly sessions, two of which were with lidocaine (5 mgs/kg) and two with placebo infusions administered over 60 minutes. Intravenous lidocaine was superior regarding the reduction of the intensity of pain, the allodynia, and the hyperalgesia compared to placebo. Moreover, contrary to placebo, lidocaine managed to maintain its therapeutic results for the first 24 hours after intravenous infusion. Although, intravenous lidocaine is not a first line treatment, when first line medications fail to help, pain specialists may try it as an add-on treatment. This trial is registered with NCT01955967.

Sign in / Sign up

Export Citation Format

Share Document